In California, Calysta has announced a Series B financing of $10 million. The round saw financing led by Walden Riverwood Ventures and Aqua-Spark, venture firms from the US and the Netherlands, respectively. Nicholas Brathwaite, Walden Riverwood Ventures and Mike Velings, Aqua-Spark, will join the Calysta Board of Directors. Calysta intends to use the Series B investment to advance development of high value nutritional products for fish and livestock as well as traditional chemical products.
The financing also included additional investment from previous investors, including Pangaea Ventures Ltd from Calysta’s Series A round, and current Calysta officers and directors.
More on the story.
